India has signed an agreement with Egypt’s Eva Pharma company for drugs and medical supplies to buy …
Search results for
"Remdesivir "
-
-
Gilead Sciences Inc priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed …
-
Gilead Sciences Inc, which makes the antiviral drug remdesivir and is now testing it for potential coronavirus …
-
FeatureIndustry & TradeTech/AI
Egypt’s drug maker, Eva Pharma to manufacture Gilead’s remdesivir for coronavirus treatment
by Sanaa Allamby Sanaa AllamEgypt-based Eva Pharma has signed a deal with Gilead Sciences for manufacturing and sale of remdesivir, which …
-
Industry & TradeTech/AI
Gilead’s Remdesivir study on monkeys shows drug reduced lung damage linked to coronavirus
Gilead Sciences’ antiviral drug remdesivir has helped to prevent macaques infected with the coronavirus from developing respiratory …
-
Gilead Sciences Inc said that its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in …
-
International NewsNews
Gilead licences drugmakers to make remdesivir coronavirus treatment in 127 countries
Gilead Sciences has signed a licencing agreement with five generic drugmakers to make antiviral drug remdesivir in …
-
unclassified
WHO to talk with U.S., Gilead to make coronavirus potential drug remdesivir more widely available
The World Health Organisation (WHO) is planning to speak with the U.S. government and biotech firm Gilead …
-
International NewsNews
U.S. FDA grants emergency use for remdesivir for very sick coronavirus patients
The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for Gilead Sciences’ remdesivir drug …
-
Industry & TradeTech/AI
Gilead says remdesivir coronavirus treatment will need a ‘sustainable model’ to keep it accessible
Gilead Sciences is doing its best to make experimental antiviral drug remdesivir accessible and affordable to coronavirus …
Newer Posts